New Drug Applications DBV Technologies Provides Update on Viaskin Peanut for Children Four to 11 Years of Age – BLA Withdrawn 6 years ago
New Drug Applications Aimmune Therapeutics Submits BLA to FDA for AR101 for the Treatment of Peanut Allergy in Children and Adolescents Ages 4–17 6 years ago